NT Mobile Menu

Search form



Are the Brains of Geniuses Different?

Cognitive deficits have been extensively studied, but what could be gained from studying the brain activity of highly intelligent individuals?


© VLADGRIN/Shutterstock.com

Recent Content

Three new multiple sclerosis studies show the promise of two drugs, amiselimod and alemtuzumab, as treatments and one, arbaclofen, for spasticity.

What happens when athletes stop training for 10 days? Dr. Lazzara discusses a study of resting cerebral blood flow in gray matter and the hippocampus.

To investigate an association between epilepsy and autoimmune disease, researchers reviewed 25 studies, covering patients of various ages.

Second-impact syndrome remains a hotly debated diagnosis. A recently published case report evoked 3 commentaries from concussion management experts.

Patients with phantom limb pain may benefit best from tailored therapy based on individual pain response coupled with attention to side effects.

Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.

Research presented at this ECTRIMS session covered management of multiple sclerosis-related fatigue, cognitive issues, and gait impairment.

By clicking Accept, you agree to become a member of the UBM Medica Community.